Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510250
Status:
COMPLETED
Last Update Posted:
2015-07-27
First Post:
2007-07-31
Brief Title:
A Phase III Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Organization Data
Organization:
University Health Network Toronto
Class:
OTHER
Study ID:
DDPDRO-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Health Network Toronto
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |